Concierge Cardiology · Chronic Management

Atrial Fibrillation Management.

Personalized, physician-led atrial fibrillation management with direct access to your cardiology team. Proactive monitoring. Faster interventions. Better outcomes.

Sandeep M. Patel, MD
Sandeep M. Patel, MD, Structural & Interventional Cardiologist
6 million Americans affected, projected 12 million by 2030
Prevalence
5x increased stroke risk without anticoagulation
Stroke Risk
21% CV event reduction with early rhythm control (EAST-AFNET 4)
Early Control
Overview

Understanding atrial fibrillation management.

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting an estimated 6 million Americans with projections reaching 12 million by 2030 (AHA Circulation, 2023). AF increases stroke risk fivefold and is associated with a twofold increase in all-cause mortality. The EAST-AFNET 4 trial demonstrated that early rhythm control — initiated within one year of diagnosis — reduces cardiovascular death, stroke, and hospitalization by 21% compared to standard rate control. Managing AF effectively requires balancing multiple competing priorities: stroke prevention with anticoagulation, symptom control through rate or rhythm management, identification of modifiable risk factors, and monitoring for complications like heart failure and tachycardia-mediated cardiomyopathy. Each of these demands frequent reassessment and rapid therapeutic adjustments. Our concierge AF program provides continuous rhythm surveillance through wearable monitors, proactive anticoagulation management, and individualized rate-versus-rhythm strategy development — ensuring patients receive the early, aggressive management that trials like EAST-AFNET 4 have shown to save lives.

Why Concierge

Why concierge cardiology for this condition.

Atrial fibrillation management is uniquely suited to concierge care because the condition is inherently unpredictable. Paroxysmal episodes may last minutes to hours and resolve before a scheduled ECG can capture them. Symptoms fluctuate — some patients are debilitated by palpitations while others have silent AF detected only by continuous monitoring. Traditional 6-month follow-up cycles miss asymptomatic AF burden progression, undertreated risk factors, and suboptimal anticoagulation. Concierge cardiology provides continuous or frequent rhythm monitoring via smartwatch integration and ambulatory ECG patches, real-time review of arrhythmia events with same-day clinical response, anticoagulation management with regular INR or drug-level monitoring, and aggressive upstream therapy targeting modifiable drivers like obesity, sleep apnea, alcohol use, and hypertension. This comprehensive approach aligns with the 2023 ACC/AHA AF management guidelines emphasizing holistic, patient-centered AF care.

What we monitor.

AF burden (% time in fibrillation) via continuous or periodic ambulatory monitoring
Heart rate control: resting and exercise heart rate trends
CHA2DS2-VASc score reassessment and anticoagulation adherence
Echocardiographic surveillance: left atrial size, LVEF, and diastolic function
Thyroid function (TSH) and electrolytes (potassium, magnesium) at regular intervals
Sleep apnea screening and CPAP compliance tracking (AF recurrence is 25% higher without OSA treatment)
Quality-of-life metrics: AFEQT score and symptom burden tracking

Our management approach.

Individualized rate vs. rhythm control strategy based on symptom burden, AF duration, and left atrial size
Early rhythm control with antiarrhythmic drugs or catheter ablation referral per EAST-AFNET 4 evidence
Anticoagulation optimization: DOAC selection based on renal function, drug interactions, and patient preference
Aggressive risk factor modification — weight management (LEGACY trial: 10% weight loss reduces AF recurrence by 6x), alcohol reduction, BP control
Sleep apnea screening and treatment coordination (OSA present in 40-50% of AF patients)
Wearable ECG integration (Apple Watch, KardiaMobile) with physician-reviewed alerts
Post-ablation surveillance: 30-day blanking period monitoring and 12-month recurrence tracking

Expected outcomes.

21% reduction in cardiovascular death and stroke with early rhythm control (EAST-AFNET 4 trial)
AF burden reduction below 5% in patients undergoing catheter ablation (CABANA trial data)
Near-elimination of stroke risk with consistent DOAC adherence (> 99% relative risk reduction vs. no anticoagulation)
Reduction in AF-related emergency department visits by 40-60% through proactive symptom management
Improved quality of life: average 15-20 point improvement in AFEQT scores within 6 months

Related concierge services.

Hypertension Management
Heart Failure Monitoring
Arrhythmia Monitoring & Device Management

Get expert atrial fibrillation management with continuous monitoring and personalized treatment strategies.

Direct physician access, proactive monitoring, and personalized care plans. Concierge cardiology starting at $295/month.

View Concierge Plans About Concierge Cardiology